Clinical trial
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First…
NCT03193788 · Asan Medical Center, Other · Unknown status
Key facts
| NCT number | NCT03193788 |
|---|---|
| Title | Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy |
| Official title | A Prospective Randomized Phase III Trial of Maintenance Pemetrexed Versus Observation in Patients With Recurrent or Metastatic Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Without Disease Progression |
| Acronym | PREMIER |
| Lead sponsor | Asan Medical Center, Other |
| Collaborators | Korean Cancer Study Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Ureter Cancer, Transitional Cell Carcinoma |
| Intervention type | Drug |
| Interventions | pemetrexed, Folic Acid, Vitamin B12 Injection, Dexamethasone |
| Enrollment | 74 |
| Start date | Jan 1, 2017 |
| Primary completion | Dec 1, 2019 |
| Completion | Jun 1, 2020 |
| First posted | Jun 21, 2017 |
| Last update posted | Jun 21, 2017 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: